Clinical Characteristics and Survival Analysis of Carbapenem-Resistant Pseudomonas Aeruginosa Colonized or Infected Patients with Hematological Disorders.
10.19746/j.cnki.issn.1009-2137.2023.04.040
- Author:
Ying-Ying SHEN
1
;
Yue-Chao ZHAO
1
;
Bo WANG
1
;
Di-Jiong WU
1
;
Qiu-Shuang LI
1
;
Yi-Ping SHEN
1
;
Jian-Ping SHEN
1
;
Jun-Min CAO
1
;
Sheng-Yun LIN
1
;
Bao-Dong YE
2
Author Information
1. Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310003, Zhejiang Province, China.
2. Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310003, Zhejiang Province, China.E-mail: 13588453501@163.com.
- Publication Type:Journal Article
- Keywords:
carbapenem-resistant Pseudomonas aeruginosa;
clinical characteristics;
hematological disorder;
survival analysis
- MeSH:
Humans;
Carbapenems/therapeutic use*;
Pseudomonas aeruginosa;
Soft Tissue Infections/drug therapy*;
Anti-Bacterial Agents/therapeutic use*;
Hematologic Diseases;
Survival Analysis
- From:
Journal of Experimental Hematology
2023;31(4):1192-1198
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the clinical characteristics and impact on mortality of carbapenem-resistant Pseudomonas aeruginosa (CRPA) colonized or infected patients with hematological disorders in order to provide evidence for the prevention and treatment of CRPA.
METHODS:The patients who were colonized or infected with CRPA in the Department of Hematology of The First Affiliated Hospital of Zhejiang Chinese Medical University from January 2020 to March 2021 were selected as the research subjects, the clinical data such as hospitalization time, primary disease treatment regimen, granulocyte count, previous infection and antibiotic regimen of these patients were analyzed, meanwhile, antibiotic regimen and efficacy during CRPA infection, 30-day and long-term survival were also analyzed.
RESULTS:A total of 59 patients were included in this study, and divided into CRPA infection group (43 cases) and CRPA colonization group (16 cases). Univariate logistic regression analysis showed that ECOG score (P =0.003), agranulocytosis (P <0.001), and exposure to upper than 3rd generations of cephalosporins and tigecycline within 30 days (P =0.035, P =0.017) were the high-risk factors for CRPA infection. Multivariate logistic regression analysis showed that ECOG score of 3/4 ( OR=10.815, 95%CI: 1.260-92.820, P =0.030) and agranulocytosis ( OR=13.82, 95%CI: 2.243-85.176, P =0.005) were independent risk factors for CRPA infection. There was a statistically significant difference in cumulative survival rate between CRPA colonization group and CRPA infection group ( χ2=14.134, P < 0.001). Kaplan-Meier survival analysis showed that the influencing factors of 30-day survival in patients with CRPA infection were agranulocytosis (P =0.022), soft tissue infection (P =0.03), and time of hospitalization before CRPA infection (P =0.041). Cox regression analysis showed that agranulocytosis was an independent risk factor affecting 30-day survival of patients with CRPA infection (HR=3.229, 95%CI :1.093-3.548, P =0.034).
CONCLUSIONS:Patients with hematological disorders have high mortality and poor prognosis after CRPA infection. Bloodstream infection and soft tissue infection are the main causes of death. Patients with high suspicion of CRPA infection and high-risk should be treated as soon as possible.